Egide SA
PAR:ALGID
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Egide SA
PAR:ALGID
|
FR |
|
A
|
Arena Pharmaceuticals Inc
F:RN3N
|
US |
|
F
|
Fix Price Group Plc
MOEX:FIXP
|
CY |
|
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
|
US |
|
Constellation Software Inc
TSX:CSU
|
CA |
|
American Water Works Company Inc
NYSE:AWK
|
US |
|
NK Russneft' PAO
MOEX:RNFT
|
RU |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ALGID's stock price target?
Not Available
ALGID doesn't have any price targets made by Wall Street professionals.
What is Egide SA's Revenue forecast?
Projected CAGR
9%
For the last 3 years the
compound annual growth rate for
Egide SA's revenue is
28%.
The projected
CAGR
for the next 3 years is
9%.